Wenzhuo He
6PUBLICATIONS
20CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (6)
Sort by Publication Date:
|Oct 21, 2024
Assessing the Prognostic Value of 13 Inflammation-Based Scores in Patients with Unresectable or Advanced Biliary Tract Carcinoma After Immunotherapy.Fang Wang, Chang Jiang, Wenzhuo He
|Sep 04, 2023
ENO2-derived phosphoenolpyruvate functions as an endogenous inhibitor of HDAC1 and confers resistance to antiangiogenic therapy.Chenran Wang, Maohua Huang, Yuning Lin
|Nov 14, 2022
Regorafenib with or without a programmed cell death protein 1 antibody as third-line treatment for microsatellite stable metastatic colorectal cancer.Wen-Zhuo He, Lei Wang, Chen-Xi Yin
|Nov 06, 2021
Association between somatic RET mutations and clinical and genetic characteristics in patients with metastatic colorectal cancer.Yuan-Zhong Yang, Wan-Ming Hu, Liang-Ping Xia
|Mar 11, 2021
Real World First-Line Treatments and Outcomes of Nab-Paclitaxel Plus Gemcitabine, mFOLFIRINOX and GEMOX in Unresectable Pancreatic Cancer from a Chinese Single Institution.Qi Quan, Yixing Wang, Fenghua Wang
|May 24, 2020
Metformin selectively inhibits metastatic colorectal cancer with the KRAS mutation by intracellular accumulation through silencing MATE1.Jinye Xie, Liangping Xia, Wei Xiang
Pageof 1
Frequent Collaborators
4 joint publications
Liangping Xia
1 joint publications
Wan-Ming Hu
1 joint publications
Lei Wang
1 joint publications
Ya-Nan Jin
1 joint publications
Gui-Fang Guo
1 joint publications
Jinye Xie
1 joint publications
Weiwei Qi
1 joint publications
Ti Zhou
1 joint publications
Chenran Wang
1 joint publications
Maohua Huang
